Image
![A light-skinned male-presenting individual with gray hair and a beard wearing a gray suit jacket and white button-up shirt against a blurred backdrop](/sites/default/files/styles/large/public/2024-01/Steve%20Finkbeiner_Scientific%20Advisory%20Board_0.jpg?itok=rjnLCXSP)
Steve Finkbeiner
ALS Breakthrough Research Fund Scientific Advisory Board Member
Steve Finkbeiner is director of the Center for Systems and Therapeutics and the Taube/Koret Center for Neurodegenerative Disease Research at Gladstone Institutes. Finkbeiner’s research is broadly focused across many neurodegenerative and psychiatric diseases. His lab has developed new patient-derived models of many diseases, including ALS, and developed state-of-the-art technologies to generate and analyze imaging and genetic data. His research emphasizes the necessity of understanding the neurobiology of disease well enough to design and produce effective therapeutics.